Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cannon

Showing results (421-430 of 1,137) with videos related to

Pageof 114
Sort By:
American Heart Journal|April 23, 2005
Early cardiac catheterization is associated with lower mortality only among high-risk patients with ST- and non-ST-elevation acute coronary syndromes: observations from the OPUS-TIMI 16 trialWarren J Cantor, Shaun G Goodman, Christopher P Cannon, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|November 19, 2008
Validation of an automated safety surveillance system with prospective, randomized trial dataMichael E Matheny, David A Morrow, Lucila Ohno-Machado, et al.
Clinical Orthopaedics and Related Research|July 4, 2014
Operative management of metastatic melanoma in bone may require en bloc resection of diseaseJeffrey E Krygier, Valerae O Lewis, Christopher P Cannon, et al.
American Heart Journal|June 2, 2015
Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODYSSEY COMBO I studyDean J Kereiakes, Jennifer G Robinson, Christopher P Cannon, et al.
Journal of Thrombosis and Thrombolysis|June 21, 2006
Cholesterol, C-reactive protein, and cerebrovascular events following intensive and moderate statin therapyJessica L Mega, David A Morrow, Christopher P Cannon, et al.
Journal of the American College of Cardiology|June 21, 2008
Thrombus precursor protein and clinical outcomes in patients with acute coronary syndromesJessica L Mega, David A Morrow, James A de Lemos, et al.
Immunogenetics|January 15, 2005
Variable domains and a VpreB-like molecule are present in a jawless vertebrateJohn P Cannon, Robert N Haire, Zeev Pancer, et al.
Endocrinology|January 29, 2000
Human placental trophoblasts secrete a disintegrin metalloproteinase very similar to the insulin-like growth factor binding protein-3 protease in human pregnancy serumJ C Irwin, L F Suen, B H Cheng, et al.
Journal of the American College of Cardiology|September 6, 2008
Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) analysisRoberto R Giraldez, Robert P Giugliano, Satishkumar Mohanavelu, et al.
The American Journal of Cardiology|August 30, 2005
C-reactive protein and cardiovascular outcomes in smokers versus nonsmokers in non-ST-elevation acute coronary syndrome (from the TACTICS-TIMI 18 trial)Nazanin Moghbeli, Ajay J Kirtane, Kausik K Ray, et al.
Pageof 114

Showing results (421-430 of 1,137) with videos related to

Sort By:
Pageof 114
American Heart Journal|April 23, 2005
Early cardiac catheterization is associated with lower mortality only among high-risk patients with ST- and non-ST-elevation acute coronary syndromes: observations from the OPUS-TIMI 16 trialWarren J Cantor, Shaun G Goodman, Christopher P Cannon, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|November 19, 2008
Validation of an automated safety surveillance system with prospective, randomized trial dataMichael E Matheny, David A Morrow, Lucila Ohno-Machado, et al.
Clinical Orthopaedics and Related Research|July 4, 2014
Operative management of metastatic melanoma in bone may require en bloc resection of diseaseJeffrey E Krygier, Valerae O Lewis, Christopher P Cannon, et al.
American Heart Journal|June 2, 2015
Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODYSSEY COMBO I studyDean J Kereiakes, Jennifer G Robinson, Christopher P Cannon, et al.
Journal of Thrombosis and Thrombolysis|June 21, 2006
Cholesterol, C-reactive protein, and cerebrovascular events following intensive and moderate statin therapyJessica L Mega, David A Morrow, Christopher P Cannon, et al.
Journal of the American College of Cardiology|June 21, 2008
Thrombus precursor protein and clinical outcomes in patients with acute coronary syndromesJessica L Mega, David A Morrow, James A de Lemos, et al.
Immunogenetics|January 15, 2005
Variable domains and a VpreB-like molecule are present in a jawless vertebrateJohn P Cannon, Robert N Haire, Zeev Pancer, et al.
Endocrinology|January 29, 2000
Human placental trophoblasts secrete a disintegrin metalloproteinase very similar to the insulin-like growth factor binding protein-3 protease in human pregnancy serumJ C Irwin, L F Suen, B H Cheng, et al.
Journal of the American College of Cardiology|September 6, 2008
Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) analysisRoberto R Giraldez, Robert P Giugliano, Satishkumar Mohanavelu, et al.
The American Journal of Cardiology|August 30, 2005
C-reactive protein and cardiovascular outcomes in smokers versus nonsmokers in non-ST-elevation acute coronary syndrome (from the TACTICS-TIMI 18 trial)Nazanin Moghbeli, Ajay J Kirtane, Kausik K Ray, et al.
Pageof 114